TSE:4502
TSE:4502Pharmaceuticals

Takeda Pharmaceutical (TSE:4502) Valuation Check After Recent Share Price Momentum

What recent performance might be telling you Takeda Pharmaceutical (TSE:4502) has caught investor attention after a recent stretch of positive returns, with the share price up over the past week, month, past 3 months and year to date. That shorter term strength sits alongside a 1 year total return figure and multi year total return track record. This has prompted some investors to compare those gains with Takeda’s reported revenue, net income and current valuation metrics. See our latest...
TSE:7735
TSE:7735Semiconductor

Is It Too Late To Consider SCREEN Holdings (TSE:7735) After Its Strong Multi Year Rally?

If you are wondering whether SCREEN Holdings is still reasonably priced after its strong run, or if the easy money has already been made, this article walks through what the current share price might actually imply about value. At a last close of ¥15,410, the stock has returned 1.1% over the past week and 12.0% over the last month, with a 56.0% return over 1 year and a very large 3 year gain of 269.1%. However, the year-to-date figure sits at a 3.7% decline and the 5 year return is...
TSE:5729
TSE:5729Metals and Mining

Top Dividend Stocks In Global For January 2026

As global markets navigate a mixed start to 2026, with U.S. stocks experiencing slight declines and European indices reaching new highs, investors are keenly observing economic indicators such as rising home sales in the U.S. and manufacturing growth in China. In this environment, identifying strong dividend stocks can be an effective strategy for those seeking steady income streams, especially given the current geopolitical tensions influencing sectors like energy.
TSE:7936
TSE:7936Luxury

Assessing ASICS (TSE:7936) Valuation After Strong One Year Shareholder Returns

ASICS share performance snapshot for retail investors ASICS (TSE:7936) has drawn attention after a recent stretch of positive returns, with the stock up 0.2% over the past day, 6.4% over the week, and about 8.7% over the past month. See our latest analysis for ASICS. Looking beyond the recent bounce, ASICS has a 1 year total shareholder return of 23.8% and a very large 5 year total shareholder return. This suggests momentum has been building as investors reassess both growth potential and...
TSE:6471
TSE:6471Machinery

Assessing Whether NSK (TSE:6471) Looks Overvalued After Strong Recent Share Price Momentum

Recent share performance and business backdrop NSK (TSE:6471) has been on investors’ radar after a period of strong share price moves, with the stock showing positive returns over the past week, month and past 3 months. That price action is set against a large, diversified bearings and automotive components business headquartered in Tokyo, with reported annual revenue of ¥811,274 and net income of ¥17,980. See our latest analysis for NSK. Against this backdrop, NSK’s recent 6.22% 7 day share...
NSE:7488
NSE:7488Healthcare

Asian Dividend Stocks: Yagami And 2 Top Picks For Income

As the Asian markets navigate a mixed economic landscape, with Japan experiencing a slight decline and China showing modest improvement in manufacturing, investors are increasingly seeking stable income opportunities through dividend stocks. In this environment, selecting stocks that offer consistent dividends can provide a reliable income stream amidst market fluctuations.
TSE:9842
TSE:9842Specialty Retail

Arclands (TSE:9842) Margin Compression To 2.1% Challenges Earnings Growth Narratives

Arclands (TSE:9842) has reported Q3 2026 results, with revenue of ¥89.5b and basic EPS of ¥22.21, providing a clear reference point for a year that has been characterized by modest top line progress and tighter profitability. The company’s quarterly revenue moved from ¥82.0b in Q4 2025 to ¥93.2b in Q2 2026, before coming in at ¥89.5b in Q3 2026. Over the same period, basic EPS ranged from ¥6.15 in Q4 2025 to ¥45.59 in Q1 2026 and ¥44.87 in Q2 2026, ahead of the latest ¥22.21 figure. With net...
TSE:7679
TSE:7679Consumer Retailing

YAKUODO HOLDINGS (TSE:7679) Q3 EPS Drop Tests Defensive Drugstore Growth Narrative

YAKUODO HOLDINGS (TSE:7679) has released its Q3 2026 numbers, with revenue at ¥40.8b and basic EPS of ¥44.06, set against trailing 12 month EPS growth of 11.3% and five year annualized EPS growth of 6.9%. The company has seen revenue move from ¥37.7b in Q3 2025 to ¥40.8b in Q3 2026. Over the same period, quarterly basic EPS shifted from ¥51.80 to ¥44.06. Investors will be weighing these figures alongside a net profit margin that sits at 2.7% versus 2.6% a year earlier as they judge how...